about
PD 0332991, a selective cyclin D kinase 4/6 inhibitor, preferentially inhibits proliferation of luminal estrogen receptor-positive human breast cancer cell lines in vitroThe regulation of cyclin D1 degradation: roles in cancer development and the potential for therapeutic inventionPalbociclib: First CDK4/6 Inhibitor in Clinical Practice for the Treatment of Advanced HR-Positive Breast CancerCombined treatment of gamma-tocotrienol with statins induce mammary tumor cell cycle arrest in G1Silk fibroin-derived nanoparticles for biomedical applications.Pathways to tamoxifen resistance.Integrative gene set analysis of multi-platform data with sample heterogeneity.Autocrine regulation of cell proliferation by estrogen receptor-alpha in estrogen receptor-alpha-positive breast cancer cell linesThe efficacy of the cyclin-dependent kinase 4/6 inhibitor in endometrial cancerEstrogen signaling and the DNA damage response in hormone dependent breast cancers.ω-3 free fatty acids and all-trans retinoic acid synergistically induce growth inhibition of three subtypes of breast cancer cell linesAblation of Akt2 induces autophagy through cell cycle arrest, the downregulation of p70S6K, and the deregulation of mitochondria in MDA-MB231 cells.Targeting the cyclin D-cyclin-dependent kinase (CDK) 4/6-retinoblastoma pathway with selective CDK 4/6 inhibitors in hormone receptor-positive breast cancer: rationale, current status, and future directionsPAI-1 plays a protective role in CCl4-induced hepatic fibrosis in mice: role of hepatocyte division.Promoting E2F1-mediated apoptosis in oestrogen receptor-α-negative breast cancer cellsCortactin modulates RhoA activation and expression of Cip/Kip cyclin-dependent kinase inhibitors to promote cell cycle progression in 11q13-amplified head and neck squamous cell carcinoma cells.Activity of the heat shock protein 90 inhibitor ganetespib in melanomaA study to investigate the role of p27 and cyclin E immunoexpression as a prognostic factor in early breast carcinoma.Amyloid-β precursor protein promotes cell proliferation and motility of advanced breast cancer.DC-SCRIPT is a novel regulator of the tumor suppressor gene CDKN2B and induces cell cycle arrest in ERα-positive breast cancer cellsNBM-HD-1: A Novel Histone Deacetylase Inhibitor with Anticancer Activity.A novel knowledge-driven systems biology approach for phenotype prediction upon genetic interventionSynergistic anticancer effects of combined γ-tocotrienol with statin or receptor tyrosine kinase inhibitor treatment.Dysregulated transcription across diverse cancer types reveals the importance of RNA-binding protein in carcinogenesis.Palbociclib for the Treatment of Estrogen Receptor-Positive, HER2-Negative Metastatic Breast Cancer.Differential control of growth, apoptotic activity, and gene expression in human breast cancer cells by extracts derived from medicinal herbs Zingiber officinale.Evaluation and integration of cancer gene classifiers: identification and ranking of plausible drivers.1,1-Bis(3'-indolyl)-1-(p-biphenyl)methane inhibits basal-like breast cancer growth in athymic nude mice.Subhepatotoxic exposure to arsenic enhances lipopolysaccharide-induced liver injury in miceGenomic analysis of estrogen cascade reveals histone variant H2A.Z associated with breast cancer progression.Cell cycle proteins in normal and chemically induced abnormal secondary palate development: a review.Effects of common germline genetic variation in cell cycle control genes on breast cancer survival: results from a population-based cohortImpaired p53 function leads to centrosome amplification, acquired ERalpha phenotypic heterogeneity and distant metastases in breast cancer MCF-7 xenografts.Activated Akt1 accelerates MMTV-c-ErbB2 mammary tumourigenesis in mice without activation of ErbB3.NetDecoder: a network biology platform that decodes context-specific biological networks and gene activities.The dietary phytochemical indole-3-carbinol is a natural elastase enzymatic inhibitor that disrupts cyclin E protein processing.Role of LM23 in cell proliferation and apoptosis and its expression during the testis developmentEZH2 and BMI1 inversely correlate with prognosis and TP53 mutation in breast cancer.Anti-invasive and antimetastatic activities of ribosomal protein S6 kinase 4 in breast cancer cellsAminoflavone induces oxidative DNA damage and reactive oxidative species-mediated apoptosis in breast cancer cells.
P2860
Q21195212-2F20D3AB-81A9-4714-BD75-98ACDEBB2D80Q21245733-3515ADC3-9B1E-4FD7-A676-D5291700D978Q26738982-B586F50A-5781-40C8-81D5-137E583897D9Q28240913-8D5C4BFE-F492-4B0C-A8DD-F673FA221AD7Q30156091-CE06B612-34DB-4ABF-8175-CB6742CC37A4Q30441001-F7F5114C-B0B0-41AA-9FD2-E744D6ADC263Q30747009-27C512AA-8A2F-4B9E-835D-4732D2C87BF9Q33403066-2775EFB9-4DB1-44DB-96C0-2774DB5E3F20Q33638023-94036AFF-6009-47F3-BFFA-967D92E8FBEEQ33646842-058CF118-A51F-4973-9BE7-F11135CA3B14Q33774367-24F34EE4-85D1-4815-939B-38246C728115Q33812880-680A51C0-37A6-45B6-B7A8-40A507C7A50DQ33816106-1920C295-26CF-4EEA-B022-40A9BBFFAFBFQ33840622-928353F2-BB42-43F0-8426-5E25D6616E49Q34006827-0C05E906-6C08-45C6-A501-9C849B4B853CQ34190232-6B4CC390-747F-4BDB-A77D-02FEBB6B4EADQ34589866-2ED70B98-0A79-47D9-95E6-3F95ADB74D50Q34756445-B5EFB45D-CD2A-4E9A-AFD7-CDEA1F8D35AAQ34969012-D5C87F6E-D765-4DBB-9E85-C4F403054321Q35079763-7A06F4D4-93AB-4F48-A192-36E119F1A89BQ35419727-6F1E402E-F471-440B-A344-4C037E098691Q35536232-409CD303-4E72-4B3B-9492-CE90A6A6CA95Q35648936-0260312B-7CC4-46C0-B006-4EC50A216AADQ35671477-496C559F-2F98-4685-8CB7-EC7ECBB93B39Q35958082-4A94DC46-AEEA-48F6-A91E-88BB0359B96BQ36206691-2A845EFD-12E8-445C-9267-71F76FD73AA6Q36294122-1F05CEE0-56EE-49EE-B8D3-AE19D23A72CDQ36393316-7ECF0ACA-0D60-4648-8D4A-6360E3D8C5C3Q36464940-A60E963F-4F64-4CE4-A1FE-D0BAE8203BE9Q36671809-AA7435BD-0E44-4775-BE2A-23618FEED24AQ36702875-9D18D7EA-7DFA-48AD-94B2-E66B64816BE1Q36787362-D8F12D0F-5A0B-4A5D-ACD7-7EF323BD94FDQ36852947-EE209D8B-415B-41E7-8934-8D3E629B69BDQ36955137-97696FDD-0701-4AD3-A8F8-81A5F9345C68Q36959048-C41F95DE-C836-40F6-B2B3-93BBB32BC831Q37018880-ABC0FBB5-42CC-4CB4-80AD-59CDB84AE3A9Q37084417-31D788FC-7C43-4F6A-BD57-B9D63F9D1D08Q37131382-25DB5D48-4386-48BD-B1F8-4DFF4936644BQ37167261-3C54D145-8B9B-4123-B3D6-88E0DA71C5C6Q37219099-07184D79-2F43-43C2-B4C6-3E905F0CCAFD
P2860
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh
2006年學術文章
@zh-hant
name
Cell cycle control in breast cancer cells.
@ast
Cell cycle control in breast cancer cells.
@en
type
label
Cell cycle control in breast cancer cells.
@ast
Cell cycle control in breast cancer cells.
@en
prefLabel
Cell cycle control in breast cancer cells.
@ast
Cell cycle control in breast cancer cells.
@en
P2093
P356
P1476
Cell cycle control in breast cancer cells.
@en
P2093
C Elizabeth Caldon
Elizabeth A Musgrove
Robert L Sutherland
Roger J Daly
P2860
P304
P356
10.1002/JCB.20690
P577
2006-02-01T00:00:00Z